Skip to content
PubMed This is a summary of 22 peer-reviewed journal articles Updated
Endocrinology

Symptoms, Warning Signs, and Adipsic Risks

At a Glance

Arginine Vasopressin Deficiency (AVP-D) causes extreme thirst, massive urine production, and frequent nighttime waking due to a lack of the water-retaining hormone vasopressin. A dangerous variant, adipsic AVP-D, destroys the thirst mechanism, requiring a strict fluid schedule to prevent severe dehydration.

Recognizing the signs of Arginine Vasopressin Deficiency (AVP-D) is essential for managing your health and avoiding dangerous complications [1][2]. Because your body lacks the “hold your water” hormone (vasopressin), your symptoms are your body’s way of trying to survive a constant state of water loss [3][4].

The Three Hallmarks of AVP-D

Most people with AVP-D experience a triad of intense symptoms that dominate their daily lives:

  1. Polydipsia (Extreme Thirst): This is not a normal thirst. It is often described as an unquenchable, “bone-deep” craving for large amounts of fluid, particularly ice-cold water [5][6].
  2. Polyuria (Excessive Urination): Your body may produce massive amounts of urine—sometimes more than 3 to 10 liters a day [3][7]. The urine is typically clear like water because it has not been concentrated by the kidneys [1].
  3. Nocturia (Nighttime Waking): The need to urinate and drink continues through the night, forcing you to wake up every 1 to 2 hours, which can lead to severe sleep deprivation [5][7].

How AVP-D Differs from Other Conditions

It is common for these symptoms to be mistaken for other issues:

  • Diabetes Mellitus: While “sugar diabetes” also causes thirst and urination, it is caused by high blood sugar [1]. In AVP-D, your blood sugar is usually normal, but your urine is unusually dilute (low specific gravity) [8].
  • Primary Polydipsia: This is a condition where a person drinks too much water out of habit or due to a psychological drive, rather than a hormone deficiency [9]. Doctors use a specialized blood test called a copeptin test to distinguish between the two, as the treatments are very different [10][11].

When Intake Can’t Keep Up: Hypernatremia

If you cannot drink enough water to replace what you are losing—perhaps because you are ill, lack access to water, or are in a medical setting—your blood sodium levels will rise [3][12]. This is called hypernatremia [3].

High sodium is dangerous because it pulls water out of your brain cells [13]. Warning signs of rising sodium that require immediate medical attention include:

  • Extreme irritability or restlessness [14].
  • Unusual sleepiness or lethargy (somnolence) [14][15].
  • Muscle twitching or weakness [16].
  • Confusion or “brain fog” [17].

The Dangerous Variant: Adipsic AVP-D

For most people, thirst is a safety net; if you lose water, your brain screams at you to drink [18]. However, a small number of patients have Adipsic AVP-D, a particularly high-risk form of the condition [17][19].

In Adipsic AVP-D, the brain’s “thirst center” (the osmoreceptors in the hypothalamus) is damaged alongside the area that makes vasopressin [18][20]. This is often caused by brain surgery, head trauma, or specific types of tumors like craniopharyngiomas [19][13]. Note that Adipsic AVP-D is usually present from the time of a specific brain injury or surgery; typical AVP-D does not generally “turn into” Adipsic AVP-D out of nowhere [18].

Why it is so dangerous:

  • No Warning System: These patients do not feel thirsty even when their body is severely dehydrated and their sodium levels are dangerously high [18][17].
  • Complex Management: Because they lack the urge to drink, they must follow a strict, “by-the-clock” fluid schedule and monitor their weight daily to ensure they are staying hydrated [18][21].
  • High Risk: This variant carries a much higher risk of repeated hospitalizations and life-threatening complications because there is no internal signal to prevent dehydration [17][22].

If you suspect you do not feel thirst normally, it is vital to discuss this with your endocrinologist immediately to create a life-saving management plan.

Common questions in this guide

What are the main symptoms of Arginine Vasopressin Deficiency?
The three primary symptoms of AVP-D are extreme, unquenchable thirst, producing massive amounts of clear urine, and waking up constantly during the night to urinate and drink.
How is AVP-D different from primary polydipsia?
While AVP-D is caused by a lack of the hormone vasopressin, primary polydipsia is the urge to drink too much water out of habit. Doctors use a specific blood test called a copeptin test to accurately tell the difference.
What is adipsic AVP-D?
Adipsic AVP-D is a dangerous variant where the brain's thirst center is damaged, often from surgery or trauma. People with this condition do not feel thirsty even when severely dehydrated, requiring them to drink water on a strict schedule.
What are the warning signs of high sodium (hypernatremia)?
If you lose too much water, your blood sodium levels can rise to dangerous levels. Warning signs include extreme irritability, unusual sleepiness, muscle twitching, and confusion or brain fog, which require immediate medical attention.
What should I do if I have AVP-D and get a stomach bug?
If an illness prevents you from drinking enough water to replace what you are losing, you are at high risk for severe dehydration. You should work with your doctor to create an emergency hydration plan for these situations.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.What is my maximum 24-hour urine volume, and how does that compare to what you expect for AVP-D?
  2. 2.Is my thirst mechanism intact, or do I show signs of adipsic AVP-D?
  3. 3.How can we differentiate my symptoms from primary polydipsia using a copeptin test?
  4. 4.What specific warning signs of hypernatremia should my family or caregivers watch for?
  5. 5.If I am unable to drink due to illness (like a stomach bug), what is our emergency plan for hydration?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (22)
  1. 1

    Time for change: Renaming Diabetes Insipidus to improve patient safety.

    Prentice M

    Clinical endocrinology 2018; (88(5)):625-626 doi:10.1111/cen.13578.

    PMID: 29460326
  2. 2

    Changing the name of diabetes insipidus: a position statement of The Working Group for Renaming Diabetes Insipidus.

    , Arima H, Cheetham T, et al.

    Endocrine journal 2022; (69(11)):1281-1284 doi:10.1507/endocrj.EJ20220831.

    PMID: 36244744
  3. 3

    Animal models of Central Diabetes Insipidus: Human relevance of acquired beyond hereditary syndromes and the role of oxytocin.

    Bernal A, Mahía J, Puerto A

    Neuroscience and biobehavioral reviews 2016; (66()):1-14.

    PMID: 27118135
  4. 4

    Diagnosis and treatment of hypernatremia.

    Tomkins M, Mc Donald D, Green D, et al.

    Best practice & research. Clinical endocrinology & metabolism 2026; (40(1)):102065 doi:10.1016/j.beem.2025.102065.

    PMID: 41203493
  5. 5

    Idiopathic Arginine Vasopressin Deficiency With an Incidental Non-functional Pituitary Microadenoma in an Elderly Diabetic Woman.

    Krishna MSV, Babu DVSP, Singh M, Madhavan S

    Cureus 2025; (17(8)):e89995 doi:10.7759/cureus.89995.

    PMID: 40951256
  6. 6

    Diabetes Insipidus: A Pragmatic Approach to Management.

    Priya G, Kalra S, Dasgupta A, Grewal E

    Cureus 2021; (13(1)):e12498 doi:10.7759/cureus.12498.

    PMID: 33425560
  7. 7

    Early central diabetes insipidus: An ominous sign in post-cardiac arrest patients.

    Chae MK, Lee JH, Lee TR, et al.

    Journal of critical care 2016; (32()):63-7.

    PMID: 26783152
  8. 8

    Coexistence of type 2 diabetes mellitus, arginine vasopressin deficiency, and Marfan syndrome: A case report.

    Le Y, Zhang J, Hong T, Yang J

    Journal of diabetes investigation 2024; (15(7)):964-967 doi:10.1111/jdi.14169.

    PMID: 38429969
  9. 9

    Vasopressin and Copeptin in health and disease.

    Christ-Crain M

    Reviews in endocrine & metabolic disorders 2019; (20(3)):283-294 doi:10.1007/s11154-019-09509-9.

    PMID: 31656992
  10. 10

    Diagnostic Utility of Copeptin in Pediatric Patients with Polyuria-Polydipsia Syndrome: A Systematic Review and Meta-Analysis.

    Ciortea DA, Petrea Cliveți CL, Bujoreanu Bezman L, et al.

    International journal of molecular sciences 2024; (25(19)) doi:10.3390/ijms251910743.

    PMID: 39409072
  11. 11

    Copeptin assays in children for the differential diagnosis of polyuria-polydipsia syndrome and reference levels in hospitalized children.

    Bonnet L, Marquant E, Fromonot J, et al.

    Clinical endocrinology 2022; (96(1)):47-53 doi:10.1111/cen.14620.

    PMID: 34694022
  12. 12

    Transient Central Diabetes Insipidus and Marked Hypernatremia following Cardiorespiratory Arrest.

    Koubar SH, Younes E

    Case reports in nephrology 2017; (2017()):1574625 doi:10.1155/2017/1574625.

    PMID: 28758038
  13. 13

    Neurosarcoidosis Presentation as Adipsic Diabetes Insipidus Secondary to a Pituitary Stalk Lesion and Association with Anti-NMDA Receptor Antibodies.

    Solis JG, Olascoaga Lugo A, Rodríguez Florido MA, et al.

    Case reports in neurological medicine 2020; (2020()):7956350 doi:10.1155/2020/7956350.

    PMID: 32670647
  14. 14

    'Un-thirsty' hypernatremia.

    Koster M, Ledergerber K, Brändle M

    Endocrinology, diabetes & metabolism case reports 2025; (2025(3)).

    PMID: 40704639
  15. 15

    Survival Following Extreme Hypernatraemia Associated with Severe Dehydration and Undiagnosed Diabetes Mellitus.

    Xiao H, Barmanray R, Qian S, et al.

    Case reports in endocrinology 2019; (2019()):4174259 doi:10.1155/2019/4174259.

    PMID: 31915553
  16. 16

    Extreme Hypernatremia due to Dehydration.

    Kamatam S, Waqar A, Chatterjee T

    Journal of medical cases 2023; (14(7)):232-236 doi:10.14740/jmc4124.

    PMID: 37560549
  17. 17

    Adipsic diabetes insipidus.

    Kothari V, Cardona Z, Eisenberg Y

    Handbook of clinical neurology 2021; (181()):261-273 doi:10.1016/B978-0-12-820683-6.00019-1.

    PMID: 34238462
  18. 18

    Adipsic diabetes insipidus patient in postoperative pituitary macroadenoma.

    García-Ruiz VR, Suárez-Rojas J, Álvarez-Gamero JC, Paz-Ibarra JL

    Revista medica del Instituto Mexicano del Seguro Social 2020; (58(6)):740-745 doi:10.24875/RMIMSS.M20000108.

    PMID: 34705407
  19. 19

    When Thirst Ceases to Exist: A Case Report and Literature Review of Adipsic Diabetes Insipidus Following Coil Embolization of a Ruptured Anterior Communicating Artery Aneurysm.

    Barnett MJ, Patel G, Lekprasert P, et al.

    Cureus 2024; (16(7)):e64207 doi:10.7759/cureus.64207.

    PMID: 38993626
  20. 20

    Acquired forms of central diabetes insipidus: Mechanisms of disease.

    Verbalis JG

    Best practice & research. Clinical endocrinology & metabolism 2020; (34(5)):101449 doi:10.1016/j.beem.2020.101449.

    PMID: 32792133
  21. 21

    Management of central diabetes insipidus.

    Garrahy A, Thompson CJ

    Best practice & research. Clinical endocrinology & metabolism 2020; (34(5)):101385 doi:10.1016/j.beem.2020.101385.

    PMID: 32169331
  22. 22

    CENTRAL DIABETES INSIPIDUS AND CHEMOTHERAPY: USE OF A CONTINUOUS ARGININE VASOPRESSIN INFUSION FOR FLUID AND SODIUM BALANCE.

    Levine JA, Karam SL, O'Connor C, et al.

    AACE clinical case reports 2018; (4(6)):e487-e492 doi:10.4158/ACCR-2018-0165.

    PMID: 30984869

This page provides educational information about AVP-D symptoms and warning signs. It does not replace professional medical advice. Always consult your endocrinologist immediately if you experience signs of severe dehydration, confusion, or unusual sleepiness.

Get notified when new evidence is published on Arginine vasopressin deficiency.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.